loadpatents
Patent applications and USPTO patent grants for Tao; Shiwei.The latest application filed is for "carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists".
Patent | Date |
---|---|
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists App 20220249443 - Cheng; Peter Tai Wah ;   et al. | 2022-08-11 |
Triazole Carboxylic Acids As Lpa Antagonists App 20220235026 - Cheng; Peter Tai Wah ;   et al. | 2022-07-28 |
Cyclobutyl Carboxylic Acids As Lpa Antagonists App 20220235027 - SHI; YAN ;   et al. | 2022-07-28 |
Cyclohexyl acid triazole azoles as LPA antagonists Grant 11,319,315 - Shi , et al. May 3, 2 | 2022-05-03 |
Cyclohexyl acid triazole azines as LPA antagonists Grant 11,267,800 - Shi , et al. March 8, 2 | 2022-03-08 |
Cycloheptyl Acids As Lpa Antagonists App 20220041572 - Cheng; Peter Tai Wah ;   et al. | 2022-02-10 |
Radioligands For Imaging The Lpa1 Receptor App 20210379210 - Cheng; Peter Tai Wah ;   et al. | 2021-12-09 |
Oxabicyclo Acids As Lpa Antagonists App 20210317131 - Cheng; Peter Tai Wah ;   et al. | 2021-10-14 |
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists App 20210244711 - CHENG; PETER TAI WAH ;   et al. | 2021-08-12 |
Cyclohexyl Acid Triazole Azines As Lpa Antagonists App 20210230143 - Shi; Yan ;   et al. | 2021-07-29 |
Cyclohexyl Acid Triazole Azoles As Lpa Antagonists App 20210163470 - Shi; Yan ;   et al. | 2021-06-03 |
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Grant 11,007,180 - Cheng , et al. May 18, 2 | 2021-05-18 |
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists Grant 11,008,300 - Shi , et al. May 18, 2 | 2021-05-18 |
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists Grant 10,662,172 - Shi , et al. | 2020-05-26 |
Triazole N-linked Carbamoyl Cyclohexyl Acids As Lpa Antagonists App 20200148665 - Shi; Yan ;   et al. | 2020-05-14 |
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists App 20200138789 - Cheng; Peter Tai Wah ;   et al. | 2020-05-07 |
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Grant 10,576,062 - Cheng , et al. | 2020-03-03 |
Triazole N-linked Carbamoyl Cyclohexyl Acids As Lpa Antagonists App 20190185446 - SHI; YAN ;   et al. | 2019-06-20 |
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists App 20180333395 - Cheng; Peter Tai Wah ;   et al. | 2018-11-22 |
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Grant 10,071,078 - Cheng , et al. September 11, 2 | 2018-09-11 |
Cyclopropanecarboxylic acid GPR120 modulators Grant 9,938,222 - Shi , et al. April 10, 2 | 2018-04-10 |
Carbamoyloxymethyl Triazole Cyclohexyl Acids As Lpa Antagonists App 20170360759 - Cheng; Peter Tai Wah ;   et al. | 2017-12-21 |
Cyclopropanecarboxylic Acid Gpr120 Modulators App 20170253554 - Shi; Yan ;   et al. | 2017-09-07 |
Bicyclo [2.2.2] Acid Gpr120 Modulators App 20160039780 - Shi; Yan ;   et al. | 2016-02-11 |
Oxabicyclo [2.2.2] acid GPR120 modulators Grant 8,962,660 - Zhang , et al. February 24, 2 | 2015-02-24 |
Oxabicyclo [2.2.2] Acid Gpr120 Modulators App 20140275173 - Zhang; Hao ;   et al. | 2014-09-18 |
Hydroxy-amino acid amides Grant 5,872,262 - Dolle, III , et al. February 16, 1 | 1999-02-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.